rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Microbot Medical Inc.

MBOT · Nasdaq

Health CareMedical DevicesNot moving yetRobotics

MBOT stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 46.8% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
29% -2 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
71 (-6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders71-6 on the quarter
New · exited12 · 18
Reported value$22.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20262,906,810$5.7M-2,715−0.1%
Mitsubishi UFJ Asset Management Co., Ltd.new · filed 7 Aug 20261,268,453$2.5M+1,268,453
BlackRock, Inc.added · filed 7 Aug 2026902,411$1.8M+45,013+5.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026836,271$1.6M+75,440+9.9%
UBS Group AGreduced · filed 13 Aug 2026806,847$1.6M-10,098−1.2%
DNB Asset Management ASunchanged · filed 11 Aug 2026677,498$1.3M00.0%
STIFEL FINANCIAL CORPadded · filed 12 Aug 2026589,924$1.2M+16,849+2.9%
MARSHALL WACE, LLPadded · filed 13 Aug 2026541,963$1.1M+60,918+12.7%
SUSQUEHANNA INTERNATIONAL GROUP, LLPreduced · filed 14 Aug 2026525,827$1.0M-398,480−43.1%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026431,033$841K+30,808+7.7%
31 Mar 2023 – 30 Jun 2026
255075Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Aileen Ptucha Stockburger Company insiderDirector · last 1 Apr 20260 · 0
David James Wilson Company insiderDirector · last 1 Apr 20260 · 0
Martin J. Madden Company insiderDirector · last 1 Apr 20260 · 0
Prattipati Laxminarain Company insiderDirector · last 1 Apr 20260 · 0
Scott R. Burell Company insiderDirector · last 1 Apr 20260 · 0
Tal Baruch Wenderow Company insiderDirector · last 1 Apr 20260 · 0
Harel Gadot Company insiderChairman, President and CEO · last 18 Feb 20260 · 1
Juan Diaz-Cartelle Company insiderChief Medical Officer · last 18 Feb 20260 · 0
Rachel Vaknin Company insiderChief Financial Officer · last 18 Feb 20260 · 0
Simon Sharon Company insiderGeneral Manager, CTO · last 18 Feb 20260 · 0
Yoseph Bornstein Company insiderDirector · last 2 Nov 20230 · 31
Eyal Morag Company insiderChief Medical Officer · last 1 Aug 20230 · 0

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+57%
ATRC AtriCureLeading+54%
HAE HaemoneticsLeading+43%
BVS BioventusLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-18.9%
Share count trendFY 2025 · to 24 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.9M
Free cash flowFY 2025 · to 31 Dec 2025−$13.1M

Analyst forecasts

No analyst forecasts yet.